Napo pharmaceuticals, jaguar health's subsidiary, bolsters management team with appointment of darlene horton, m.d. as chief medical officer

San francisco, ca / accesswire / may 26, 2021 / napo pharmaceuticals inc., the wholly-owned subsidiary of jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company"), announced today the appointment of darlene horton, m.d., a biopharmaceutical veteran and leading clinical development expert, to the role of chief medical officer (cmo) for napo.
JAGX Ratings Summary
JAGX Quant Ranking